RGS12, a novel inflammatory mediator for rheumatoid arthritis

Ended Project Grant Awarded Last action

Award ID
W81XWH2110509
Recipient
Awarding agency
Obligated
$812,344

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

About this award

The Trustees of the University of Pennsylvania received a $812,344 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on A Novel Inflammatory Mediator for Rheumatoid Arthritis from July 15, 2021 through July 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield medicine. This award will allow the University of Pennsylvania to conduct research into new inflammatory mediators that could potentially aid treatment of rheumatoid arthritis.

Quick answers

Who received award W81XWH2110509?

W81XWH2110509 was awarded to The Trustees Of The University Of Pennsylvania by Medical Command (Department of the Army) on July 15, 2021.

How much is award W81XWH2110509 worth?

$812,344 has been obligated on W81XWH2110509.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award